Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) will present clinical data from its metabolic disease, ophthalmology and rare disease pipelines at the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE